I-Linagliptin CAS: 668270-12-0 Umkhiqizi Umhlinzeki Isithombe Esivelele

Umhlinzeki Womkhiqizi we-Linagliptin CAS: 668270-12-0

I-Linagliptin (amagama okuhweba i-Tradjenta ne-Trajetna) iyisithiyo se-dipeptidyl peptidase-4 (DPP-4) esavunywa yi-US FDA ngoMeyi 2011 ekwelapheni isifo sikashukela sohlobo 2 kanye nokudla nokuzivocavoca. I-Linagliptin (BI-1356) ichazwe njengesithiyo esinamandla kakhulu, esikhetha kancane futhi esisebenza isikhathi eside se-DPP-4. I-Linagliptin yavela emizamweni yokwenza ngcono izithiyo ze-DPP-4 ezisekelwe ku-xanthine kanye nomphumela wokuqala otholakale emkhankasweni we-HTS.

Oda noma Cela Isilinganiso

Imininingwane Yomkhiqizo

Amathegi Omkhiqizo

Ukusetshenziswa kanye Nomphumela

I-Linagliptin (TrajentaR, TradjentaTM, TrazentaTM, TrayentaTM) iyisivimbeli somlomo esikhetha kakhulu i-dipeptidyl peptidase-4 futhi iyisidakamizwa sokuqala sekilasi layo esisuswa kakhulu ngendlela engeyona eyezinso. I-Linagliptin iboniswa ukusetshenziswa kanye ngosuku ekwelapheni abantu abadala abanesifo sikashukela sohlobo 2. I-Linagliptin isebenza ukwehlisa amazinga kashukela egazini ngokuvimbela i-enzyme DPP-4, ngaleyo ndlela ivimbele ukuwohloka kwama-hormone e-incretin (i-glucagon-like peptide-1 [GLP-1] kanye ne-glucose-dependent insulinotropic peptide) kanye nokunciphisa ukuphuma kweglucose ngemuva kokudla.

Isampula Yomkhiqizo

Ukupakisha Umkhiqizo:

Ulwazi Olwengeziwe:

Ukwakheka	C25H28N8O2
Ukuhlolwa	99%
Ukubukeka	Impuphu emhlophe
Inombolo ye-CAS	668270-12-0
Ukupakisha	25KG
Impilo Yeshelufu	iminyaka engu-2
Isitoreji	Gcina endaweni epholile neyomile
Isitifiketi	I-ISO.